HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: L'Oreal Partners With Founders Factory; Beauty Device Market; Grush Gaming Toothbrush

This article was originally published in The Rose Sheet

Executive Summary

L'Oreal's strategic investment in the Founders Factory will give it access to early-stage startups built around digital beauty innovations, the firm says. More news in brief.

You may also be interested in...



Beauty Launches In Brief: Silk'n Titan Anti-Aging Device; Walgreens' Crowd-Sourced YourGoodSkin; More

The FDA-cleared Silk'n Titan uses three forms of energy to "tighten facial skin," according to marketer Home Skinovations; Walgreens Boots Alliance unveils YourGoodSkin, a line it says was co-created by a community of consumers who provided input over a two-year period. More beauty launch news in brief.

L’Oreal’s Digital Investment Grows With Partech Ventures Partnership

The French beauty leader is committed to integrating digital into the heart of its business and recognizes that infusions from external innovators are vital to keeping the system pumping. The firm’s investment in a tech- and digital-focused fund managed by Partech Ventures will connect it with startup technologies and services “that can transform people’s relationship to beauty.”

P&G May Be Simpler, More Efficient, But Investors Anxious For Growth

Firm has largely completed its portfolio trimming and restructuring and continues to see productivity gains, but organic growth fell short of many investors' expectations in fiscal 2015, inching up 1% for the year. During a fiscal 2015 full-year earnings call July 30, analysts questioned P&G's strategy, expected timing for improvements and whether recent divestitures will have the impact the firm foresees.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019937

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel